Iron supplements may boost brain development in children with HIV
Nov 04, 2024
Carolyn Marks and Joel Svensson
In this interview, conducted at SfN 2024 in Chicago, News Medical speaks with Joel Svensson and Carolyn Marks of Atlas Antibodies, about their new launch, the MolBoolean™, as well as how conferences like SfN are helping shape the future of neuroscience research.
Send to us